English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Tuesday, March 31, 2020
Dyadic宣布与药明生物达成非排他性研究许可协议
Dyadic宣布與藥明生物達成非排他性研究許可協議
Monday, March 30, 2020
Dyadic Announces Nonexclusive Research License with WuXi Biologics
Thursday, May 9, 2019
Dyadic and Serum Institute of India to Develop and Manufacture Globally Affordable and Accessible Antibody Products and Vaccines
Dyadic携手印度血清研究所 Serum研发和制造 全球广泛使用且可负担得起的抗体产品和疫苗
Dyadic攜手印度血清研究所 Serum研發和製造 全球廣泛使用且可負擔得起的抗體產品和疫苗

Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575